Publications by authors named "Rocio D Marchese"

Claim this Profile
S
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age.
Susan J Ermlich, Charles P Andrews, Steven Folkerth, Richard Rupp, David Greenberg, Rocio D Marchese

Vaccine· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants.
David Greenberg, Patricia A Hoover, Timo Vesikari, Christopher Peltier, David C Hurley, Rocio D Marchese

Vaccine· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes.
Karen L Ciprero, Rocio D Marchese, Patrick Richard, Martine Baudin, Tina M Sterling

Hum Vaccin Immunother· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults.
Richard McFetridge, Ajoke Sobanjo-Ter Meulen, Steven D Folkerth, John A Hoekstra, Michael Dallas, Rocio D Marchese

Vaccine· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability and immunogenicity of 15-valent pneumococcal conjugate vaccine in toddlers previously vaccinated with 7-valent pneumococcal conjugate vaccine.
Ajoke Sobanjo-ter Meulen, Timo Vesikari, Edgardo A Malacaman, Steven A Shapiro, Michael J Dallas, Rocio D Marchese

Pediatr Infect Dis J· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of a new multiplex binding assay versus the enzyme-linked immunosorbent assay for measurement of serotype-specific pneumococcal capsular polysaccharide IgG.
David Goldblatt, Lindsey Ashton, Yuhua Zhang, Joseph Antonello, Rocio D Marchese

Clin Vaccine Immunol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults.
Daniel M Musher, Susan B Manoff, Richard D McFetridge, Charles L Liss, Rocio D Marchese

Hum Vaccin· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years.
Susan B Manoff, Charles Liss, Michael J Caulfield, Rocio D Marchese, Jeffrey Silber

J Infect Dis· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.
Daniel M Musher, Susan B Manof, Charlie Liss, Richard D McFetridge, Rocio D Marchese

J Infect Dis· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustainability of humoral responses to varicella vaccine in pediatric transplant recipients following a pretransplantation immunization strategy.
Michelle Barton, Samia Wasfy, Toni Melbourne, Diane Hébert, Dorothy Moore, Rocio D Marchese

Pediatr Transplant· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.
Adriana Weinberg, Jane H Zhang, Michael N Oxman, Gary R Johnson, Anthony R Hayward, Rocio D Marchese

J Infect Dis· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization and validation of a multiplex, electrochemiluminescence-based detection assay for the quantitation of immunoglobulin G serotype-specific antipneumococcal antibodies in human serum.
Rocio D Marchese, Derek Puchalski, Pamela Miller, Joseph Antonello, Olivia Hammond

Clin Vaccine Immunol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complexities of clinical assay development and optimization prior to first-in-man immunization trials - a description of immunogenicity assay development for the testing of samples from a phase 1 Alzheimer's vaccine trial.
Olivia Hammond, James Reynolds, Leonard J Rubinstein, Daniel Sikkema, Rocio D Marchese

J Immunoassay Immunochem· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection.
Olivia Hammond, Yue Wang, Tina Green, Joseph Antonello, Robert Kuhn, Rocio D Marchese

J Med Virol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assay.
Rocio D Marchese, Neil T Jain, Joseph Antonello, Laura Mallette, Kristin L Butterfield-Gerson

Clin Vaccine Immunol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memory T cells and vaccines.
Mark T Esser, Rocio D Marchese, Lisa S Kierstead, Lynda G Tussey, Fubao Wang

Vaccine· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis